Outcome of patients with interstitial lung diseases admitted to the intensive care unit

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 30, Issue 2, 2013, Pages 134-142

  Vial Dupuy, A ^a,b   Sanchez, O ^a,b   Douvry, B ^a,b   Guetta, L ^a,b   Juvin, K ^b   Wermert, D ^b   Guerot E ^b   Israël Biet, Dominique ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Drug induced interstitial lung disease; Fibrosing idiopathic interstitial pneumonitis; Interstitial lung disease

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; DIAGNOSIS RELATED GROUP; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; HOSPITAL MORTALITY; INTERSTITIAL LUNG DISEASE;

HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LUNG DISEASES, INTERSTITIAL; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 84885143680     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ryu JH, Daniels CE, Hartman TE, et al. Diagnosis of interstitial lung diseases. Mayo Clin Proc 2007; 82: 976-86. (Pubitemid 47206373)
2. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 636-43. (Pubitemid 47503070)
3. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006; 27: 143-50. (Pubitemid 43092678)
4. Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214-20. (Pubitemid 47068224)
5. Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011; 37: 356-63.
6. Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103: 846-53.
7. Blivet S, Philit F, Sab JM, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001; 120: 209-12. (Pubitemid 32744881)
8. Fumeaux T, Rothmeier C, Jolliet P. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med. 2001; 27: 1868-74. (Pubitemid 33145071)
9. Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med. 2008; 102: 1355-9.
10. Mollica C, Paone G, Conti V, et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 2010; 79: 209-15.
11. Saydain G, Islam A, Afessa B, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002; 166: 839-42.
12. Stern JB, Mal H, Groussard O, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 2001; 120: 213-9. (Pubitemid 32744882)
13. Camus P, Fanton A, Bonniaud P, et al. Interstitial lung disease induced by drugs and radiation. Respiration. 2004; 71: 301-26. (Pubitemid 39179164)
14. Antoniou KM, Margaritopoulos G, Economidou F, et al. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009; 33: 882-96.
15. Ramsey J, Amari M, Kantrow SP. Pulmonary vasculitis: clinical presentation, differential diagnosis, and management. Curr Rheumatol Rep 2010; 12: 420-8.
16. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002; 165: 277-304.
17. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
18. Travis WD, Hunninghake G, King TE, Jr., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177: 1338-47. (Pubitemid 351860911)
19. Goldhill DR, Sumner A. APACHE II, data accuracy and outcome prediction. Anaesthesia 1998; 53: 937-43. (Pubitemid 28466825)
20. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama 1993; 270: 2957-63. (Pubitemid 24000804)
21. Lee J, Yim JJ, Yang SC, et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int 2011: Sep 27 [Epub ahead of print].
22. Tomii K, Tachikawa R, Chin K, et al. Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med 2010; 49: 1341-7.
23. Yokoyama T, Kondoh Y, Taniguchi H, et al. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 2010; 49: 1509-14.
24. Fernandez-Perez ER, Yilmaz M, Jenad H, et al. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 2008; 133: 1113-9.
25. http://www.agence-biomedecine.fr/uploads/document/ Repartition%20pour%20site%20fev%202010.pdf. 2012.
26. Barlesi F, Villani P, Doddoli C, et al. Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol 2004; 18: 85-91. (Pubitemid 38200923)
27. Imokawa S, Colby TV, Leslie KO, et al. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373-81. (Pubitemid 30085968)
28. Sumpter K, Harper-Wynne C, O'Brien M, et al. Severe acute interstitial pnuemonia and gefitinib. Lung Cancer 2004; 43: 367-8. (Pubitemid 38224159)
29. Tachikawa R, Tomii K, Ueda H, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 2012; 83: 20-7.
30. Kim R, Meyer KC. Therapies for interstitial lung disease: past, present and future. Ther Adv Respir Dis 2008; 2: 319-38.